MedPath

comparison of two drugs Fentanyl and Dexmedetomidine for anaesthetising patients undergoing laparoscopic gynaecological surgery

Phase 4
Completed
Conditions
Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding
Registration Number
CTRI/2018/09/015593
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.ASA grade I-II patients

2.Patients undergoing laparoscopic gynaecological surgery

Exclusion Criteria

1.Patient refusal to participate

2.Uncontrolled systemic illnesses

3.Patients with BMI >30

4.Patients with cardiac arrhythmias and conduction blocks

5.Patients on beta blockers

6.Patients with documented autonomic dysfunction

•Known hypersensitivity to Opioids or Dexmeditomidine

•Patients on any drug included in the study for chronic treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of recovery profile in both groupsTimepoint: during the period of surgery and till 6 hours postoperatively
Secondary Outcome Measures
NameTimeMethod
1.Intra-operative Hemodynamic profile <br/ ><br>2. serum cortisol levels to assess stress response <br/ ><br>3.PONV <br/ ><br>4.Patient satisfaction score <br/ ><br>5.Time to first rescue analgesic <br/ ><br>Timepoint: 1.Intraoperative hemodynamic parameters every 30 min for the duration of surgery <br/ ><br>2.serum cortisol levels just before induction, at 30 min and at 60 min <br/ ><br>3. patient will be followed up for a period of 6hrs postoperatively
© Copyright 2025. All Rights Reserved by MedPath